Budesonide inhaler in Tanzania: NEMLIT level, who can prescribe it and STG references
Budesonide inhaler is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level B (health centre). It is not on the DukaDawa pharmacy network yet, so we show no brands or prices for it. The Standard Treatment Guidelines mention it in 3 sections.
Last updated
New to DukadawaRx? Register as a prescriber. Licensed prescribers only; we verify your registration before you can prescribe.
Is budesonide inhaler available on the DukaDawa pharmacy network?
Not yet. Budesonide inhaler is not in the DukaDawa network catalogue, so we have no brands, prices or stock for it.
Prescribers can still write it on a DukadawaRx prescription, and we show it here as soon as a network pharmacy lists it.
Is budesonide inhaler on the NEMLIT, and who can prescribe it?
Yes. Budesonide inhaler is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level B (health centre). At level B it may be prescribed by specialists, medical officers, dental officers, assistant medical officers and clinical officers.
- Level
- B (health centre)
- Category
- Anti-asthmatics (Medicines Acting on Respiratory Tract)
- Listed forms
- Inhalation: 100mcg, 200mcg
- Page
- NEMLIT, p. 27
| Level | Facility | Who may prescribe |
|---|---|---|
| A | Dispensary | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer, Assistant Clinical Officer |
| B (listed) | Health centre | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer |
| C | Council or district hospital | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer |
| D | Regional referral hospital | Specialist, Medical Officer, Dental Officer |
| S | Zonal, special and national hospitals | Specialist |
A medicine is listed from the lowest facility level where it should be available.
Where is budesonide inhaler in the Standard Treatment Guidelines?
The Standard Treatment Guidelines (7th edition, 2026) mention budesonide inhaler in 3 sections, most often section 9.4.1.1 Obstructive Lung Diseases > Asthma > Management of Chronic Asthma (p. 210). See the STG for treatment details.
- 9.4.1.1 Obstructive Lung Diseases > Asthma > Management of Chronic Asthma, p. 210
- 7.3 Drug Resistance Tuberculosis (DR-TB), p. 163
- 9.4.2 Obstructive Lung Diseases > Chronic Obstructive Pulmonary Disease (COPD), p. 214
Sections that mention Budesonide inhaler, most mentions first. Positions only: see the STG for treatment details.
Related medicines
- BeclometasoneNEMLIT B · Not on the DukaDawa network yet
- Beclometasone + FormoterolNEMLIT C · Not on the DukaDawa network yet
- Budesonide + FormoterolNEMLIT C · Not on the DukaDawa network yet
- Fluticasone propionateNEMLIT D · Not on the DukaDawa network yet
- FormoterolNEMLIT C · Not on the DukaDawa network yet
- MontelukastNEMLIT A, D · Not on the DukaDawa network yet
- SalbutamolNEMLIT C · Not on the DukaDawa network yet
- SalmeterolNEMLIT C · Not on the DukaDawa network yet
Sources
- Standard Treatment Guidelines and National Essential Medicines List (STG/NEMLIT), 7th edition, 2026, Ministry of Health, United Republic of Tanzania
Page last updated
STG positions are section numbers and printed page numbers only.
This page supports licensed prescribers and pharmacists. It is not medical advice and does not replace the Standard Treatment Guidelines, the product information or professional judgement. Prices and stock change often: confirm with the pharmacy.